Cell and Gene Therapy Catapult

Stevenage, UK
National Center
CAR-T Cell Therapy AAV
Program data pending ClinicalTrials.gov matching · Last scored 2026-03-15
59.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (3)

Quick Facts: Cell and Gene Therapy Catapult

Signal Score
59.0/100 (as of 2026-03-15)
Quality Compliance
Assessment pending
Headquarters
Stevenage, UK
Modalities
CAR-T, Cell Therapy, AAV
Active CGT Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CGT manufacturing intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 CGT manufacturing site: Stevenage, UK
Modalities: CAR-T, Cell Therapy, AAV
Capacity assessment: 58.0/100
Sites: Stevenage, UK
Source: SEC EDGAR, press monitoring, company profiles
1 CGT manufacturing site
Recent Press3 articles
1 CGT manufacturing site: Stevenage, UK
Modalities: CAR-T, Cell Therapy, AAV
Capacity assessment: 58.0/100

Recent News 3 articles

regulatory 2026-03-15
ELRIG’s inaugural Cell and Gene Therapy event proves its value - Cambridge Independent
ELRIG’s inaugural Cell and Gene Therapy event proves its value  Cambridge Independent
Source →
capacity 2026-03-12
Digital Manufacturing Must Lead The Next Phase Of Cell And Gene Therapy Scale Up - BioSpectrum Asia
Digital Manufacturing Must Lead The Next Phase Of Cell And Gene Therapy Scale Up  BioSpectrum Asia
Source →
general 2026-02-19
Cell and Gene Therapy Catapult Establishes Technology Advisory Board - The Medicine Maker
Cell and Gene Therapy Catapult Establishes Technology Advisory Board  The Medicine Maker
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
CAR-T CDMOs → Cell Therapy CDMOs → AAV CDMOs →